Trim 30-40% of BA exposure, cap residual at 1.0% NAV with layered stops and pre-earnings exit
The Underweight rating reflects a binding synthesis of three constraints: confirmed multi-timeframe downtrend (price below 10 EMA $192.90, 50 SMA $211.56, 200 SMA $220.60; MACD negative since mid-August; RSI 27-32) combined with 46x forward P/E on $4.13 EPS against a $17.8B cumulative four-year loss base and ~0% operating margin, where the bull's own valuation framework contains a material arithmetic error ($7 EPS × 20x = $140 is -26% from $189.82, not upside); against a full Sell due to defended institutional floor at $187, $62.6B deferred revenue, $620B backlog, $20.9B liquidity, and binary catalysts (Q3 earnings, defense supplemental, 777-9 first delivery) within 30-90 days historically producing ±10-20% single-day moves; with 1.0% NAV sizing chosen over 1.5% because marginal 50bps adds $500K asymmetric downside exposure on high-beta (1.26) industrial with ATR $6.11-6.45 ahead of heavily skewed earnings distribution (six of last eight quarters missed/guided conservatively).
| Position | Action |
|---|---|
| Core position | Trim 30-40% of existing exposure at $189.82 |
| Residual cap | Cap residual at 1.0% of NAV (vs proposed 1.5% or 0.5%) |
| Pre-earnings | Exit at least half of residual position before Q3 2026 earnings print |
| Rally short | Shorts only on rallies to $205+ with tight stops above $215 |
Boeing at $189.82 is a deeply discounted call option on the global commercial aerospace recovery, anchored by a fortress balance sheet, operating in a duopoly, with multiple near-term catalysts, supported by a quiet-but-constructive sentiment backdrop and a fading nationalization tail risk.
| Indicator | Value | Signal |
|---|---|---|
| Close | $189.82 | bearish |
| 10 EMA | $192.90 | bearish |
| 50 SMA | $211.56 | bearish |
| 200 SMA | $220.60 | bearish |
| RSI(14) | 37.86 | bearish |
| RSI(14) - Oversold Low 2026-09-28 | 27.45 | bearish |
| MACD | -5.92 | bearish |
| MACD Histogram | ≈0 | neutral |
| Bollinger Lower Band | $182.23 | bearish |
| Bollinger Middle Band | $197.95 | bearish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Q3 earnings clean print (positive FCF, gross margin >10%, 737 production rate ≥38/mo sustained, credible 2027 guidance)
Then: Add second tranche
Descending triangle resolving to upside at major support confluence
↩ rebuts: “Bear's interpretation of lower highs as continuation pattern”
EV: +29% to +37% (12-month target $245-260 from $189.82) · concedes: Macro is not friendly: 10Y at 23-year highs, 30Y at 2002 highs, 96% probability of no Fed cuts in 2026; Clean TTM EPS is roughly negative after stripping one-off gains; Forward P/E of 46x embeds recovery expectations; TTM P/E of 68x is expensive; Underlying business lost ~$6B before unusual items (stripping Jeppesen gain)
Boeing is a structurally broken industrial trading at 46x forward P/E that embeds a recovery it has failed to deliver for 4+ years; the stock is in a confirmed technical downtrend with deteriorating fundamentals, negative FCF, $17.8B in cumulative net losses, and a debt-to-equity ratio that produces negative tangible book value—making the risk-reward unfavorable for long investors.
· concedes: The bull correctly notes that long-end yields at 2002 highs are a structural headwind for long-duration assets; The bull correctly accepts the $9.7B Jeppesen gain argument; The defense $63B deferred revenue is 'real' (though it doesn't translate to profits due to negative-margin fixed-price contracts); The $20.9B in cash does buy multiple years of runway (though at the cost of equity value destruction); A beat on 737 MAX deliveries, 787 cadence, or defense margin could theoretically trigger a short squeeze
→ vs conservative: National champion/duopoly argument has cost shareholders billions over past four years; hold is taking maximum risk because technical, fundamental, and macro data all align to downside while recovery story requires four simultaneous execution miracles
→ vs conservative: Cumulative losses of $17.8B over four years, operating margin near zero, gross margin 4.7% vs historical 17% norm, negative FCF—holding at 67x trailing earnings into 30-year Treasury highs is aggressive risk-taking without even realizing it
→ vs neutral: Neutral 5/10 sentiment score means zero institutional news flow, retail round-tripping, and opaque voting event that may have resolved; valuation is not meaningless at 52-week low when unanchored to reality (46x forward EPS with near-zero margins and negative FCF)
→ vs neutral: Wait-and-see position is freezing while stock makes lower highs on volume; 50 SMA rolling over from $223 in June to $211 today; MACD histogram flattening at zero not because selling exhausted but because nothing left to sell
→ vs neutral: Underweight is not a bet against the company but a bet against the price at $189.82 in October 2026; valuation is meaningless when unanchored to reality with operating margins near zero, negative TTM FCF, and rising cost of capital
| Bollinger Upper Band |
| $213.66 |
| bearish |
| ATR(14) | 6.11 | neutral |
Support: 187.72 · 182.23 · 176.77 | Resistance: 192.9 · 197.95 · 211.56 · 213.66 · 220.6
BA exhibits uniformly bearish technical alignment with price ($189.82) below all three trend moving averages (10 EMA $192.90, 50 SMA $211.56, 200 SMA $220.60) and trading in the lower half of Bollinger Bands ($182.23–$213.66). Momentum is bearish but exhausting: MACD histogram has flattened near zero after reaching -5.0s through September, and RSI has recovered from oversold (27.45 on 2026-09-28) to 37.86. ATR(14) at 6.11 indicates elevated but normalizing volatility. The September 2026 breakdown on 18.05M shares represents a distribution event, and the stock has formed a series of lower highs since the January 2026 high of $254.14. Trading stance is HOLD (defensive) with no new long entries until a confirmed close above the 10 EMA at $192.90 with RSI reclaim of 45–50 and flattening/positive MACD histogram.
Market Cap
$150.0 B
Share Price
~$190
P/E (TTM)
67.8×
Forward P/E
46.0×
PEG Ratio
1.39
P/B
24.6×
EPS (TTM)
$2.80
Forward EPS
$4.13
Dividend Yield
0.0%
Beta
1.26
52-Week High
$254.35
52-Week Low
$176.77
50-Day Avg
$211.99
200-Day Avg
$220.68
FY2025 Revenue
$89,463 M
FY2025 Gross Profit
$4,289 M
FY2025 Gross Margin
4.8%
FY2025 Operating Income
$(5,416) M
FY2025 Operating Margin
(6.1%)
FY2025 Net Income
$2,235 M
FY2025 Diluted EPS
$2.48
FY2025 Diluted Shares
762.3 M
FY2025 EBITDA
$7,359 M
FY2025 FCF
$(1,886) M
FY2025 Other Income/Unusual
$10,822 M
FY2025 Net Interest Expense
$(2,771) M
FY2025 R&D
$3,615 M
FY2025 SG&A
$6,090 M
FY2025 Tax Provision
$397 M
FY2025 Pretax Income
$2,635 M
FY2024 Revenue
$66,517 M
FY2024 Gross Profit
$(1,991) M
FY2024 Gross Margin
(3.0%)
FY2024 Operating Income
$(10,824) M
FY2024 Operating Margin
(16.3%)
FY2024 Net Income
$(11,817) M
FY2024 Diluted EPS
$(18.36)
FY2024 Diluted Shares
647.2 M
FY2024 EBITDA
$(7,649) M
FY2024 Net Equity Issued
+$23,857 M
FY2023 Revenue
$77,794 M
FY2023 Gross Profit
$7,724 M
FY2023 Gross Margin
9.9%
FY2023 Operating Income
$(821) M
FY2023 Net Income
$(2,222) M
FY2023 Diluted EPS
$(3.67)
FY2022 Revenue
$66,608 M
FY2022 Gross Profit
$3,530 M
FY2022 Gross Margin
5.3%
FY2022 Operating Income
$(3,509) M
FY2022 Net Income
$(4,935) M
FY2022 Diluted EPS
$(8.30)
TTM Revenue
$94.0 B
TTM EBITDA
$(2.9) B
TTM Net Income
$2.09 B
TTM FCF
$5.63 B
TTM Gross Margin
4.7%
TTM Operating Margin
~0%
TTM Net Margin
2.6%
TTM ROE
173.5%
Cash & ST Investments (Mar 2026)
$20,905 M
Total Assets (Mar 2026)
$164,787 M
Total Debt (Mar 2026)
$47,209 M
Net Debt (Mar 2026)
$37,768 M
Stockholders' Equity (Mar 2026)
$5,987 M
Inventory (Mar 2026)
$87,225 M
Current Deferred Revenue (Mar 2026)
$62,591 M
Current Ratio (Mar 2026)
1.18
Debt/Equity (Mar 2026)
7.88×
Tangible Book Value
negative ~$13 B
Clean FY2025 Underlying Net Income
~$6 B loss
2024 Net Equity Issued
$23,857 M
Strengths
Concerns
Boeing presents a leveraged recovery story where the stock trades at ~46× forward P/E on assumed production ramp assumptions, despite underlying operations still losing approximately $6 billion annually before one-off gains. The balance sheet has been materially repaired through a ~$24 billion equity raise in 2024 and a ~$9.7 billion Jeppesen divestiture gain in 2025, restoring positive stockholders' equity for the first time since 2022 and reducing debt by ~$7 billion in Q1 2026, while maintaining $20.9 billion in liquidity. However, profitability remains critically weak with gross margins at 4.8% versus historical norms of ~17%, operating cash flow essentially breakeven, and free cash flow negative on a trailing twelve-month basis — the market is paying for 2027+ earnings power that requires successful 737 MAX production ramp to high-30s/low-40s per month, defense margin recovery, and eventual China delivery re-opening.
Macro: Higher-for-longer macro backdrop with 10Y and 30Y Treasury yields at highest levels since 2002; mortgage rates at 7.58% near 3-year high; Fed officials publicly hawkish with 96% probability priced for zero rate cuts in 2026; Iran war driving inflation beyond oil through supply-side shocks; S&P 500 and Nasdaq printed record highs to start October led by Nvidia/AMD; US recession odds at 6% by end-2026 (down 2pp week-over-week) supporting soft-landing base case.